We analyze the evolutionary dynamics of ninety carbapenem-resistant Acinetobacter 25 baumannii (CRAB) isolates collected between 1990 and 2015 in Chile. CRAB were 26 identified at first in an isolate collected in 2005, which harbored the ISAba1-bla OXA-69 27 arrangement. Later, OXA-58-and OXA-23-producing A. baumannii strains emerged in 28 2007 and 2009, respectively. This phenomenon was associated with variations in the 29 epidemiology of OXA-type carbapenemases, linked to nosocomial lineages belonging to 30 ST109 (CC1), ST162 (CC79), ST15 (CC15) and ST318 (CC15).
representative of the main PFGE clusters were subjected to whole-genome sequencing 76 (WGS), and sequence types (STs) were determined (Pasteur's scheme) as published earlier 77 (16).
78
OTCs genes were screened by multiplex-PCR (17), whereas bla OXA-51-like alleles 79 were investigated by PCR and sequencing. ISAba1-bla OXA-51-like array was examined by 80 conventional PCR (18). CarbAcinetoNP test was performed on all carbapenem non-81 susceptible isolates that were negative for bla OXA genes (19).
82
The comprised isolates were grouped into three different periods: P1 (1990-1999, 83 n= 27), P2 (2000-2009, n= 30), and P3 (2010-2015, n= 33) . Consequently, carbapenem 84 resistance was confirmed in 56 (62%) isolates, being identified for the first time in 2005 in 85 a strain (A329, P2) carrying the ISAba1-bla OXA-69 array (Figure 1 ). XDR, MDR or PDR 86 profiles were displayed by 51 (57%), 28 (31%) and 3 (3%) isolates, respectively.
87
Furthermore, 65 (72%) isolates were non-susceptible to amikacin, whereas 64 (71%) were 88 non-susceptible to gentamicin. Additionally, 32 (36%) isolates exhibited resistance to 89 ampicillin-sulbactam, and 4 (3.6%) were colistin-resistant.
90
Further, bla OXA-58 (30%) and bla OXA-23 (30%) genes were more prevalent and were 91 associated with highest carbapenems MICs (Figure 1) . The ISAba1-bla OXA-219 array was 92 observed in 14 of 56 (25%) CRAB isolates. In this regard, OXA-58-producing isolates 93 5 seems to have emerged in 2007, whereas ISAba1-OXA-219 and OXA-23 producers arose 94 in 2009, being disseminated among different hospitals.
95
As expected, no OTC producers were identified in P1. Otherwise, eleven OXA-58-, 96 seven OXA-23-, and four ISAba1-bla OXA-51 -like-positive CRAB isolates were detected in 97 P2 (Figure 1) . In P3, a change in the molecular epidemiology of circulating OTCs was 98 observed, where OXA-23 producers (n= 11) were predominant, followed by OXA-51-like 99 (associated with ISAba1, n= 15)-and OXA-58 (n= 4)-positive isolates (Figure 1) .
100
Interestingly, the CRAB isolate A223 was negative for both CarbAcinetoNP and OTCs ICs (15). Interestingly, OXA-219 was originally identified in 2012 from a single isolate 141 from Chile, being related to the worldwide (WW) clone 4 (27), associated to the ISAba1-142 bla OXA-219 array. These results suggest the presence of an endemic lineage (WW4, OXA-143 219) coexisting with a regional lineage (ST15) in Chile (8, 28), which has been described in 144 Brazil (29) and Ecuador (28).
145
Other identified lineages included ST109 (CC1), ST162 (CC79), and ST318 146 (CC15). ST109 has been originally identified in Sweden (30), whereas ST162 and ST318 147 have been described in Brazil (29, 31) . These findings reaffirm that the major lineages 148 present in the region are different to those globally spread (8). However, ICII and III have 149 been lately identified in Peru (32), which might have an important impact on the local 150 epidemiology.
151
In conclusion, our study provides data about evolutionary dynamics of CRAB 152 circulating in Chilean hospitals, which were linked to particular lineages as well as to the 153 emergence of specific OTCs, whereas colistin resistance deserves an urgent attention to 154 strengthen surveillance. 
